Context first
At 20 weeks' gestation, intrauterine death (IUD) is normally managed by medical induction/evacuation (misoprostol +/- mifepristone), not LSCS — the uterus is easily induced at this gestation and surgery carries more risk. LSCS at this stage is reserved for specific indications: transverse/unstable lie with ruptured membranes, placenta previa with active bleeding, a scarred uterus (e.g., prior classical CS) where induction is contraindicated, failed induction, or maternal compromise needing rapid delivery. If that is the clinical situation here, the anesthetic principles below apply.
Pre-anesthetic check specific to IUD
Before giving any neuraxial block in an IUD case, confirm:
- Coagulation profile and platelet count — retained dead fetus (especially >3-4 weeks) or associated abruption/sepsis can trigger consumptive coagulopathy/DIC, which is an absolute contraindication to spinal anesthesia.
- No sepsis/chorioamnionitis — untreated sepsis is a contraindication to neuraxial technique.
- Hemodynamic stability — if there is concealed hemorrhage or septic shock, general anesthesia is safer than spinal.
If these are clear, spinal anesthesia is preferred over general anesthesia for LSCS, as in any obstetric case, because it avoids airway/aspiration risk and excessive drug transfer.
Spinal dosing
The surgical block needed for any LSCS (regardless of gestational age at 20 weeks or term) is a sensory level of T4-T6, because the peritoneal incision and uterine exteriorization require this height even though the fundus itself is smaller at 20 weeks.
- Drug: Hyperbaric bupivacaine 0.5% is the standard agent - Morgan & Mikhail's Clinical Anesthesiology, and NYSORA note it has replaced 0.75% bupivacaine and hyperbaric tetracaine/lidocaine for obstetric spinals.
- Term dose (for comparison): 1.6-2.0 mL (8-10 mg), sometimes titrated to 1.8-2.2 mL (9-11 mg), typically combined with fentanyl 15-25 mcg +/- morphine 100-150 mcg for post-op analgesia.
- 20-week (mid-trimester) dose: Pregnancy reduces spinal/epidural local anesthetic requirement by roughly 25% versus the non-pregnant state, due to epidural venous engorgement, reduced CSF volume, and increased neural sensitivity to local anesthetic - but this reduction is progressive through pregnancy and is most pronounced near term because aortocaval compression and epidural venous distension from the gravid uterus are maximal then. At 20 weeks the uterus is not yet compressing the vena cava or epidural veins to the same degree as at term, so most anesthesiologists use a dose closer to (but still somewhat below) the standard non-obstetric spinal dose rather than the fully reduced term-obstetric dose.
In practice this generally means:
- Hyperbaric bupivacaine 0.5%, ~1.8-2.5 mL (9-12.5 mg), dosed by the patient's height (Morgan & Mikhail/NYSORA note weight has little additional effect on spread once height is accounted for), aiming for a T4-T6 sensory block.
- Add fentanyl 15-25 mcg intrathecally for better intraoperative quality, since there is no live fetus to consider regarding opioid transfer.
- Position: sitting or lateral, L3-L4 or L2-L3 interspace, pencil-point (Whitacre/Sprotte) needle 25G to reduce post-dural-puncture headache risk.
- Left lateral tilt/wedge is less critical than at term (aortocaval compression is minimal before ~20 weeks but can begin developing near the end of the second trimester), but is still reasonable practice.
- Have vasopressor (phenylephrine boluses/infusion) ready for hypotension, though hypotension is typically less severe than with a term parturient.
There is no single universally published "20-week LSCS spinal dose" table in the standard anesthesia texts (Miller's Anesthesia, Barash's Clinical Anesthesia, Morgan & Mikhail) because mid-trimester cesarean for IUD is uncommon; the dose is extrapolated from general obstetric spinal dosing principles and titrated to achieve the T4-T6 block, generally landing between the non-pregnant adult dose and the standard term-cesarean dose.
Bottom line recommendation
- Confirm coagulation status and absence of sepsis first.
- Hyperbaric bupivacaine 0.5%, approximately 1.8-2.5 mL (9-12.5 mg) intrathecally, plus fentanyl 15-25 mcg, height-based dosing, targeting T4-T6 block.
- Have vasopressors and full resuscitation/GA backup ready, as with any neuraxial obstetric anesthetic.
This reflects general anesthesia principles from Morgan & Mikhail's Clinical Anesthesiology and NYSORA's obstetric regional anesthesia guidance; there is no dedicated randomized trial data for this specific mid-trimester IUD-LSCS scenario, so dosing is derived from standard obstetric spinal principles rather than population-specific studies. If you can share the actual indication for LSCS in this case (why induction wasn't chosen) and the patient's coagulation/sepsis status, I can refine this further.